Acorah Software Products - Accounts Production 16.4.675 false true 31 December 2024 1 January 2024 false 1 January 2025 31 July 2025 31 July 2025 10451053 Mr John Abernethie iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10451053 2024-12-31 10451053 2025-07-31 10451053 2025-01-01 2025-07-31 10451053 frs-core:CurrentFinancialInstruments 2025-07-31 10451053 frs-core:ComputerEquipment 2025-01-01 2025-07-31 10451053 frs-core:FurnitureFittings 2025-01-01 2025-07-31 10451053 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2025-01-01 2025-07-31 10451053 frs-core:MotorVehicles 2025-01-01 2025-07-31 10451053 frs-core:PlantMachinery 2025-01-01 2025-07-31 10451053 frs-core:ShareCapital 2025-07-31 10451053 frs-core:RetainedEarningsAccumulatedLosses 2025-07-31 10451053 frs-bus:PrivateLimitedCompanyLtd 2025-01-01 2025-07-31 10451053 frs-bus:FilletedAccounts 2025-01-01 2025-07-31 10451053 frs-bus:SmallEntities 2025-01-01 2025-07-31 10451053 frs-bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-07-31 10451053 frs-bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-07-31 10451053 frs-core:UnlistedNon-exchangeTraded 2025-07-31 10451053 frs-core:UnlistedNon-exchangeTraded 2024-12-31 10451053 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-12-31 10451053 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-07-31 10451053 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-12-31 10451053 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-07-31 10451053 frs-bus:Director1 2025-01-01 2025-07-31 10451053 frs-countries:EnglandWales 2025-01-01 2025-07-31 10451053 2023-12-31 10451053 2024-12-31 10451053 2024-01-01 2024-12-31 10451053 frs-core:CurrentFinancialInstruments 2024-12-31 10451053 frs-core:ShareCapital 2024-12-31 10451053 frs-core:RetainedEarningsAccumulatedLosses 2024-12-31 10451053 frs-core:CurrentFinancialInstruments 1 2024-12-31
Registered number: 10451053
Aristospray Limited
Unaudited Financial Statements
For the Period 1 January 2025 to 31 July 2025
Montacs
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—3
Page 1
Balance Sheet
Registered number: 10451053
31 July 2025 31 December 2024
Notes £ £ £ £
FIXED ASSETS
Investments 4 100 100
100 100
CURRENT ASSETS
Debtors 5 - 218,348
Cash at bank and in hand 100 198
100 218,546
Creditors: Amounts Falling Due Within One Year 6 (100 ) (557,074 )
NET CURRENT ASSETS (LIABILITIES) - (338,528 )
TOTAL ASSETS LESS CURRENT LIABILITIES 100 (338,428 )
NET ASSETS/(LIABILITIES) 100 (338,428 )
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account - (338,528 )
SHAREHOLDERS' FUNDS 100 (338,428)
For the period ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr John Abernethie
Director
22/08/2025
The notes on pages 2 to 3 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Aristospray Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10451053 . The registered office is Granville House, Wallingford Road, Uxbridge, UB8 2RW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Research and Development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research is recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised to ... on a straight line basis over their expected useful economic lives, which range from ... to ... years.
If it is not possible to distinguish between the research phase and the development phase of an internal project the expenditure is treated as if it were all incurred in the research phase only.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold 10% straight line
Plant & Machinery 25% straight line
Motor Vehicles 25% straight line
Fixtures & Fittings 25% straight line
Computer Equipment 25% straight line
3. Average Number of Employees
Average number of employees, including directors, during the period was: 1 (2024: 1)
1 1
4. Investments
Unlisted
£
Cost or Valuation
As at 1 January 2025 100
As at 31 July 2025 100
Provision
As at 1 January 2025 -
As at 31 July 2025 -
Net Book Value
As at 31 July 2025 100
As at 1 January 2025 100
Page 2
Page 3
5. Debtors
31 July 2025 31 December 2024
£ £
Due within one year
Other debtors - 180,000
Other debtors (1) - 38,348
- 218,348
6. Creditors: Amounts Falling Due Within One Year
31 July 2025 31 December 2024
£ £
Other creditors - 544,610
Amounts owed to group undertakings 100 12,464
100 557,074
7. Share Capital
31 July 2025 31 December 2024
£ £
Allotted, Called up and fully paid 100 100
Page 3